The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

The effect of idoxifene, a novel anti-oestrogen with less agonist activity than tamoxifen, was compared with that of tamoxifen on the growth of hormone-dependent MCF-7 breast cancer xenografts. Forty tumours were established with oestradiol support in ovariectomized athymic mice, allowed to grow to...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, S. R., Riddler, S., Haynes, B. P., A'Hern, R., Smith, I. E., Jarman, M., Dowsett, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063408/
https://www.ncbi.nlm.nih.gov/pubmed/9062399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063408/
https://www.ncbi.nlm.nih.gov/pubmed/9062399

Ejemplares similares